Louis Valiquette

Sherbrooke, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network.

Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network.

Journal: Human vaccines & immunotherapeutics

Published: April 29, 2026

Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) network.

Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) network.

Journal: Human vaccines & immunotherapeutics

Published: April 28, 2026

Safety of mRNA COVID-19 Vaccination during Pregnancy: Findings from Post-vaccination Follow-up Data from the Canadian National Vaccine Safety Network.

Safety of mRNA COVID-19 Vaccination during Pregnancy: Findings from Post-vaccination Follow-up Data from the Canadian National Vaccine Safety Network.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

Published: March 11, 2026

Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

Journal: JAMA network open

Published: February 27, 2026

Safety of co-administration of COVID-19 and seasonal influenza vaccines in individuals with autoimmune diseases from the Canadian National Vaccine Safety Network.

Safety of co-administration of COVID-19 and seasonal influenza vaccines in individuals with autoimmune diseases from the Canadian National Vaccine Safety Network.

Journal: Human vaccines & immunotherapeutics

Published: September 18, 2025

Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023.

Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023.

Journal: Epidemiology and infection

Published: June 23, 2025

mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety network.

mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety network.

Journal: Vaccine

Published: May 23, 2025

P robiotics i nfluencing r esponse of a ntibodies over t ime in s eniors after CO VID-19 v accine (PIRATES-COV): a randomised controlled trial protocol.

P robiotics i nfluencing r esponse of a ntibodies over t ime in s eniors after CO VID-19 v accine (PIRATES-COV): a randomised controlled trial protocol.

Journal: BMJ open

Published: March 19, 2025

Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network.

Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network.

Journal: Open forum infectious diseases

Published: December 11, 2024

Recent Vaccination Against SARS-CoV-2 Is Associated with Less Severe Disease in Working-Age Adults.

Recent Vaccination Against SARS-CoV-2 Is Associated with Less Severe Disease in Working-Age Adults.

Journal: International journal of environmental research and public health

Published: September 25, 2024

mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort study.

mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort study.

Journal: Lancet regional health. Americas

Published: June 06, 2024

Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study.

Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study.

Journal: Vaccine

Published: May 13, 2024

Showing 1-12 of 108

Last Updated: 09/26/2026